Gedunin has been demonstrated to disrupt the interaction between Hsp90 and key proteins, including Beclin-1 and Bcl-2, thereby inducing increased apoptosis in A549 lung cancer cells (Hasan et al., 2020). The gene discussed is BCL2; the disease is lung carcinoma.